|
1
|
Padhya KT, Marrero JA and Singal AG:
Recent advances in the treatment of hepatocellular carcinoma. Curr
Opin Gastroenterol. 29:285–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Groulx JF, Giroux V, Beauséjour M,
Boudjadi S, Basora N, Carrier JC and Beaulieu JF: Integrin α6A
splice variant regulates proliferation and the Wnt/β-catenin
pathway in human colorectal cancer cells. Carcinogenesis.
35:1217–1227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paul I, Bhattacharya S, Chatterjee A and
Ghosh MK: Current understanding on EGFR and Wnt/β-catenin signaling
in glioma and their possible crosstalk. Genes Cancer. 4:427–446.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen P, Zhao X and Ma L: Downregulation of
microRNA-100 correlates with tumor progression and poor prognosis
in hepatocellular carcinoma. Mol Cell Biochem. 383:49–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheung TH, Man KN, Yu MY, Yim SF, Siu NS,
Lo KW, Doran G, Wong RR, Wang VW, Smith DI, et al: Dysregulated
microRNAs in the pathogenesis and progression of cervical neoplasm.
Cell Cycle. 11:2876–2884. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bae HJ, Jung KH, Eun JW, Shen Q, Kim HS,
Park SJ, Shin WC, Yang HD, Park WS, Lee JY, et al: MicroRNA-221
governs tumor suppressor HDAC6 to potentiate malignant progression
of liver cancer. J Hepatol. 63:408–419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai JW, Xue HZ and Zhang C:
Down-regulation of microRNA-143 is associated with colorectal
cancer progression. Eur Rev Med Pharmacol Sci. 20:4682–4687.
2016.PubMed/NCBI
|
|
8
|
Zhang HB, Sun LC, Ling L, Cong LH and Lian
R: miR-143 suppresses the proliferation of NSCLC cells by
inhibiting the epidermal growth factor receptor. Exp Ther Med.
12:1795–1802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mao Y, Liu J, Zhang D and Li B: miR-143
inhibits tumor progression by targeting FAM83F in esophageal
squamous cell carcinoma. Tumour Biol. 37:9009–9022. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Johannessen C, Moi L, Kiselev Y, Pedersen
MI, Dalen SM, Braaten T and Busund LT: Expression and function of
the miR-143/145 cluster in vitro and in vivo in human breast
cancer. PLoS One. 12:e01866582017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Takahashi S, Tasaka A, Yoshima T,
Ochi H and Chayama K: Involvement of microRNA-224 in cell
proliferation, migration, invasion, and anti-apoptosis in
hepatocellular carcinoma. J Gastroenterol Hepatol. 28:565–575.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang FT, Peng JF, Cheng WJ, Zhuang YY,
Wang LY, Li CQ, Tang J, Chen WY, Li YH and Zhang SN: miR-143
targeting TAK1 attenuates pancreatic ductal adenocarcinoma
progression via MAPK and NF-κB pathway in vitro. Dig Dis Sci.
62:944–957. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao N, Wang R, Zhou L, Zhu Y, Gong J and
Zhuang SM: MicroRNA-26b suppresses the NF-κB signaling and enhances
the chemosensitivity of hepatocellular carcinoma cells by targeting
TAK1 and TAB3. Mol Cancer. 13:352014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khafaei M, Samie S, Mowla SJ, Alvanegh AG,
Mirzaei B, Chavoshei S, Dorraj GS, Esmailnejad M, Tavallaie M and
Nourani M: Evaluation of miR-9 and miR-143 expression in urine
specimens of sulfur mustard exposed patients. Interdiscip Toxicol.
8:169–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, et al: miR-143 decreases prostate
cancer cells proliferation and migration and enhances their
sensitivity to docetaxel through suppression of KRAS. Mol Cell
Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Borralho PM, Simões AE, Gomes SE, Lima RT,
Carvalho T, Ferreira DM, Vasconcelos MH, Castro RE and Rodrigues
CM: miR-143 overexpression impairs growth of human colon carcinoma
xenografts in mice with induction of apoptosis and inhibition of
proliferation. PLoS One. 6:e237872011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He J, Qian X, Carpenter R, Xu Q, Wang L,
Qi Y, Wang ZX, Liu LZ and Jiang BH: Repression of miR-143 mediates
Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8
pathway. Toxicol Sci. 134:26–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szele E, Gombos K, Juhász K, Wohler V,
Kovács A and Ember I: Effects of purified glycerol from biodiesel
on miRNAs compared to the expression profile of selected mRNAs in
Balb/c mice. In Vivo. 27:107–111. 2013.PubMed/NCBI
|
|
20
|
Mosquera JM, Sboner A, Zhang L, Chen CL,
Sung YS, Chen HW, Agaram NP, Briskin D, Basha BM, Singer S, et al:
Novel MIR143-NOTCH fusions in benign and malignant glomus tumors.
Genes Chromosomes Cancer. 52:1075–1087. 2013. View Article : Google Scholar : PubMed/NCBI
|
